|
|
|
|
thalidomide
A drug that belongs to the family of drugs called angiogenesis inhibitors. It prevents the growth of new blood vessels into a solid tumor. (National Cancer Institute)
Crash Damages for Disabled Man's Family 17 Mar 2005
The family of a Bristol thalidomide victim who died when he was crushed to death by a runaway trailer was awarded £425,000 agreed damages today. ... Scotsman,
Research and Markets: Business Development and R&D Database ... 17 Mar 2005
Chimax, Drogenil, Flutamide, EULEXIN, Onconase, IM862, MDX-010, Erbitux, Eladem, GTI-2040, Apomine, Eflornithine, Doxil, GTI-2501, Thalidomide, TG4010, KRX-0401 ... PR Newswire (press release)
TVF stocks up for MipDoc 17 Mar 2005
Maverick Television's hour for Channel 4 about the 50th anniversary of so-called wonder drug thalidomide is getting a MipTV launch, courtesy of factual sales ... C21Media (subscription),
New lease of life for thalidomide as cancer treatment? Mar 8, 2005
The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down ... Medical News Today,
Study: Thalidomide Helps Pancreas Cancer Patients Mar 7, 2005
LONDON (Reuters) - The controversial drug thalidomide slows weight loss in patients suffering from advanced pancreatic cancer, doctors said Tuesday. ... Reuters
Thalidomide could help cancer fight Mar 8, 2005
Although people who took 200mg of thalidomide daily during tests did not live longer than those who did not, their increased weight was matched by increased ... Scotsman,
Thalidomide Slows Cancer-Related Weight Loss Mar 8, 2005
TUESDAY, March 8 (HealthDay News) -- Thalidomide, long associated with birth defects, may have a good side: a small study finds the drug helps slow the weight ... Forbes
Thalidomide may have cancer role: Mar 7, 2005
...[World News]: LONDON, March 7 : British researchers Monday reported thalidomide, no longer widely used because it causes birth defects, may be an effective ... New Kerala,
Thalidomide offers cancer treatment hope Mar 8, 2005
The infamous drug thalidomide offers improved quality of life to patients with terminal pancreatic cancer, scientists have shown. ... DeHavilland,
Thalidomide could Be Helpful in Fighting Cancers Mar 8, 2005
The patients had already lost 10 percent of their weight. They were given either thalidomide or a dummy drug. ... Thalidomide didn't increase their life span. ... Money Plans,
Thalidomide could be used to treat cancer Mar 8, 2005
Paris - Thalidomide, one of the pharmaceutical industry's most nightmarish episodes, may have a second life ahead of it as a drug to help cancer victims ... Independent Online,
Thalidomide - new treatment for cancer Mar 8, 2005
Thalidomide, famous in the 60's because of limb deformities in babies born to women who had taken it for morning sickness, was withdrawn in 1961. ... News-Medical.net,
Thalidomide attenuates weight loss and wasting in pancreatic ... Mar 8, 2005
Thalidomide was first marketed in Europe in the late 1950's. It ... pregnancy. At that time no one knew thalidomide caused birth defects. ... Xagena.it,
The Return of Thalidomide Feb 23, 2005
Most people who recognize the name “thalidomide� associate it with “birth defects.� Introduced in the late 1950s, this drug was marketed as a sleeping ... rarediseases.about.com
1968: Damages for thalidomide children Feb 18, 2005
...to be awarded under a settlement agreed in the High Court to 62 children born with deformities, after their mothers took the drug thalidomide during pregnancy. ... BBC News,
New Lease of Life for Thalidomide as Cancer Treatment? Mar 7, 2005
...[Thalidomide in the treatment of cancer cachexia: a ... Gut 2004;54: 447-8]. Newswise — The drug thalidomide may have a new lease of life as a cancer treatment. ... Newswise (press release)
Thalidomide may have cancer role Mar 7, 2005
British researchers Monday reported thalidomide, no longer widely used because it causes birth defects, may be an effective treatment for pancreatic cancer. ... Big News Network.com,
Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).
Pharmion to Expand Data Package for EMEA Application for ... May 19, 2004
...to provide additional clinical data and resubmit its application with the European Medicines Evaluation Agency (EMEA) for the use of Thalidomide Pharmion 50mg ... Yahoo News (press release) - May 19, 2004
... to provide additional clinical data and resubmit its application with the European Medicines Evaluation Agency (EMEA) for the use of Thalidomide Pharmion 50mg ...
Pharmion to Expand Data Package for EMEA Application for ... PR Newswire (press release) - May 19, 2004
Current Myeloma Application Withdrawn, ENL Application Remains on File Company Reaffirms Thalidomide Sales and Guidance for 2004 BOULDER, Colo., May 19 ...
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... Yahoo News (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM - News) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... PR Newswire (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion soars on FDA ok of VidazaCBS MarketWatch - May 20, 2004
... In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... PR Newswire UK (press release)
Pharmion to Expand Data Package for EMEA Application for ... May 19, 2004
Current Myeloma Application Withdrawn, ENL Application Remains on File Company Reaffirms Thalidomide Sales and Guidance for 2004 BOULDER, Colo., May 19 ... PR Newswire (press release) - May 19, 2004
Current Myeloma Application Withdrawn, ENL Application Remains on File Company Reaffirms Thalidomide Sales and Guidance for 2004 BOULDER, Colo., May 19 ...
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... Yahoo News (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM - News) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... PR Newswire (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion soars on FDA ok of VidazaCBS MarketWatch - May 20, 2004
... In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... PR Newswire UK (press release)
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... May 3, 2004
FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM - News) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ... Yahoo News (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM - News) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... PR Newswire (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion soars on FDA ok of VidazaCBS MarketWatch - May 20, 2004
... In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... PR Newswire UK (press release)
Pharmion Appoints Lipomed Swiss and Austrian Distributor for ... May 3, 2004
FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ... PR Newswire (press release) - May 3, 2004
... FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) announced today that it has appointed Lipomed as its exclusive distributor of Thalidomide Pharmion in ...
Pharmion soars on FDA ok of VidazaCBS MarketWatch - May 20, 2004
... In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... PR Newswire UK (press release)
Pharmion soars on FDA ok of Vidaza May 20, 2004
In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ... CBS MarketWatch - May 20, 2004
... In other news, Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... PR Newswire UK (press release)
Phase II Studies of TRISENOX in Multiple Myeloma and ... May 20, 2004
...of Rush Medical Centre, published in Leukemia Research, concluded that the combination of TRISENOX(R) (arsenic trioxide) injection and thalidomide in patients ... PR Newswire UK (press release)
Pharmion Gets 'Full Approval' For Vidaza In MDS Subtypes May 20, 2004
...it plans to provide additional clinical data and resubmit its application with the European Medicines Evaluation Agency for the use of Thalidomide Pharmion 50 ... BioWorld Online (subscription) - May 20, 2004
... it plans to provide additional clinical data and resubmit its application with the European Medicines Evaluation Agency for the use of Thalidomide Pharmion 50 ...
News 8 Austin | Drug for lupus lesionsNews 8 Austin
Drug for lupus lesions May 16, 2004
Thalidomide is a risky but successful drug used to treat lupus. The result is a rash on the skin. Usually it can be treated by use ... News 8 Austin
Phase II Studies of TRISENOX in Multiple Myeloma and ... May 19, 2004
...of Rush Medical Center, published in Leukemia Research, concluded that the combination of TRISENOX(R) (arsenic trioxide) injection and thalidomide in patients ... PR Newswire (press release) - May 19, 2004
... of Rush Medical Center, published in Leukemia Research, concluded that the combination of TRISENOX(R) (arsenic trioxide) injection and thalidomide in patients ...
Phase II Studies of TRISENOX in Multiple Myeloma and ... Yahoo News (press release) - May 19, 2004
... of Rush Medical Center, published in Leukemia Research, concluded that the combination of TRISENOX® (arsenic trioxide) injection and thalidomide in patients ...
Drug for lupus lesionsNews 8 Austin
Phase II Studies of TRISENOX in Multiple Myeloma and ... May 19, 2004
...of Rush Medical Center, published in Leukemia Research, concluded that the combination of TRISENOX® (arsenic trioxide) injection and thalidomide in patients ... Yahoo News (press release) - May 19, 2004
... of Rush Medical Center, published in Leukemia Research, concluded that the combination of TRISENOX® (arsenic trioxide) injection and thalidomide in patients ...
Drug for lupus lesionsNews 8 Austin
Drug for lupus lesions May 16, 2004
...use of sunscreens and topical medications, but in more stubborn cases, doctors at Wake Forest University Baptist Medical Center in Winston-Salem use thalidomide ... News 8 Austin
Gap, Marvell Tech, Serena Software May 20, 2004
Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose to treat ... CBS MarketWatch - May 20, 2004
... Pharmion also said it plans to provide additional clinical data and re-submit its application for the use of thalidomide in a 50 milligram dose to treat ...
$1 Billion Pharmion?Motley Fool - May 20, 2004
... Celgene's Revlimid, a potent formulation of thalidomide, is reported to be highly effective in MDS patients who have a specific genetic defect. ...
Pharmion Corporation Announces First Quarter 2004 Financial ... Yahoo News (press release) - May 3, 2004
For the first quarter of 2004, net sales totaled $15.7 million, including named patient and compassionate use thalidomide sales of $12.6 million. ...
Pharmion Corporation Announces First Quarter 2004 Financial ... PR Newswire (press release) - May 3, 2004
Revenue Growth Driven by Increased Named Patient Sales of Thalidomide Company Increases Guidance for 2004 BOULDER, Colo., May 3 /PRNewswire-FirstCall ...
FDA Puts Weight Behind Blood DiseaseForbes - May 20, 2004
... Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ...
Strong medicineRocky Mountain News
$1 Billion Pharmion? May 20, 2004
Celgene's Revlimid, a potent formulation of thalidomide, is reported to be highly effective in MDS patients who have a specific genetic defect. ... Motley Fool - May 20, 2004
... Celgene's Revlimid, a potent formulation of thalidomide, is reported to be highly effective in MDS patients who have a specific genetic defect. ...
Pharmion Corporation Announces First Quarter 2004 Financial ... Yahoo News (press release) - May 3, 2004
For the first quarter of 2004, net sales totaled $15.7 million, including named patient and compassionate use thalidomide sales of $12.6 million. ...
Pharmion Corporation Announces First Quarter 2004 Financial ... PR Newswire (press release) - May 3, 2004
Revenue Growth Driven by Increased Named Patient Sales of Thalidomide Company Increases Guidance for 2004 BOULDER, Colo., May 3 /PRNewswire-FirstCall ...
FDA Puts Weight Behind Blood DiseaseForbes - May 20, 2004
... Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ...
Strong medicineRocky Mountain News
Pharmion Corporation Announces First Quarter 2004 Financial ... May 3, 2004
For the first quarter of 2004, net sales totaled $15.7 million, including named patient and compassionate use thalidomide sales of $12.6 million. ... Yahoo News (press release) - May 3, 2004
For the first quarter of 2004, net sales totaled $15.7 million, including named patient and compassionate use thalidomide sales of $12.6 million. ...
Pharmion Corporation Announces First Quarter 2004 Financial ... PR Newswire (press release) - May 3, 2004
Revenue Growth Driven by Increased Named Patient Sales of Thalidomide Company Increases Guidance for 2004 BOULDER, Colo., May 3 /PRNewswire-FirstCall ...
FDA Puts Weight Behind Blood DiseaseForbes - May 20, 2004
... Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ...
Strong medicineRocky Mountain News
Pharmion Corporation Announces First Quarter 2004 Financial ... May 3, 2004
Revenue Growth Driven by Increased Named Patient Sales of Thalidomide Company Increases Guidance for 2004 BOULDER, Colo., May 3 /PRNewswire-FirstCall ... PR Newswire (press release) - May 3, 2004
Revenue Growth Driven by Increased Named Patient Sales of Thalidomide Company Increases Guidance for 2004 BOULDER, Colo., May 3 /PRNewswire-FirstCall ...
FDA Puts Weight Behind Blood DiseaseForbes - May 20, 2004
... Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ...
Strong medicineRocky Mountain News
FDA Puts Weight Behind Blood Disease May 20, 2004
Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ... Forbes - May 20, 2004
... Revlimid is an improved version of thalidomide, which is sold by Celgene in the United States and Pharmion elsewhere as a treatment for multiple myeloma, a ...
Strong medicineRocky Mountain News
Strong medicine May 20, 2004
...from Vidaza. Pharmion also sells thalidomide in Europe on a case-by-case basis, prior to formal regulatory approval. The company ... Rocky Mountain News
Schaeffer's Midday Options Update Features Boston Scientific, ... May 20, 2004
...before midday. The firm also reaffirmed its outlook for thalidomide sales of between $51 million and $56 million for 2004. On the ... Business Wire (press release)
Pharmion upgraded to "overweight" May 20, 2004
...to JP Morgan Securities’ research note published yesterday, Pharmion reported 1Q05 revenues ahead of expectations due to an increase in thalidomide sales in ... New Ratings - May 20, 2004
... to JP Morgan Securities’ research note published yesterday, Pharmion reported 1Q05 revenues ahead of expectations due to an increase in thalidomide sales in ...
Harvard University Gazette | Westhoff assails FDA on rulingHarvard University Gazette
Westhoff assails FDA on ruling May 20, 2004
Today it is available only through prescription and is subject to restrictions that apply only to the most dangerous drugs, such as Thalidomide and Accutane. ... Harvard University Gazette
Resources from the National Cancer Institute on thalidomide:
|
|
|
| |
